BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 96 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $7,000 | +16.7% | 5,903 | -7.2% | 0.00% | – |
Q3 2019 | $6,000 | +50.0% | 6,360 | +295.0% | 0.00% | – |
Q2 2019 | $4,000 | -20.0% | 1,610 | 0.0% | 0.00% | – |
Q1 2019 | $5,000 | 0.0% | 1,610 | 0.0% | 0.00% | – |
Q4 2018 | $5,000 | -54.5% | 1,610 | 0.0% | 0.00% | – |
Q3 2018 | $11,000 | +120.0% | 1,610 | +163.9% | 0.00% | – |
Q2 2018 | $5,000 | 0.0% | 610 | 0.0% | 0.00% | – |
Q1 2018 | $5,000 | +25.0% | 610 | +19.6% | 0.00% | – |
Q4 2017 | $4,000 | -42.9% | 510 | -14.4% | 0.00% | – |
Q3 2017 | $7,000 | +16.7% | 596 | +20.2% | 0.00% | – |
Q2 2017 | $6,000 | 0.0% | 496 | 0.0% | 0.00% | – |
Q1 2017 | $6,000 | -33.3% | 496 | -9.0% | 0.00% | – |
Q4 2016 | $9,000 | -18.2% | 545 | 0.0% | 0.00% | – |
Q3 2016 | $11,000 | +120.0% | 545 | +32.9% | 0.00% | – |
Q2 2016 | $5,000 | +25.0% | 410 | 0.0% | 0.00% | – |
Q1 2016 | $4,000 | – | 410 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 1,051,441 | $3,070,000 | 0.79% |
X-Square Capital, LLC | 109,832 | $321,000 | 0.25% |
KNOTT DAVID M | 111,427 | $325,000 | 0.15% |
ARK Investment Management | 1,033,491 | $3,018,000 | 0.12% |
Baker Brothers Advisors | 2,677,818 | $7,819,000 | 0.06% |
HARVEY CAPITAL MANAGEMENT INC | 31,200 | $91,000 | 0.05% |
DAFNA Capital Management LLC | 30,000 | $88,000 | 0.04% |
WASATCH ADVISORS LP | 953,368 | $2,784,000 | 0.04% |
FRANKLIN STREET ADVISORS INC /NC | 51,415 | $150,000 | 0.02% |
FARALLON CAPITAL MANAGEMENT LLC | 1,000,000 | $2,920,000 | 0.02% |